Clinical trial
Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP…
NCT00040131 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00040131 |
|---|---|
| Title | Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bile Duct Diseases, Biliary Tract Diseases, Gallbladder Diseases, Pancreatitis, Pancreatic Diseases |
| Intervention type | Drug |
| Interventions | IL-10 |
| Enrollment | 316 |
| Start date | Jan 1, 2002 |
| Primary completion | Dec 1, 2002 |
| Completion | Jan 1, 2003 |
| First posted | Jun 21, 2002 |
| Last update posted | Nov 2, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: